California COVID-19 State Agency Guidance (April 5, 2021)

California Department of Public Health (CDPH)

• Monoclonal Antibody Treatment Information for Providers and Facilities  (updated 03/29/2021)
  • The updated guidance removes information about bamlanivimab monotherapy and includes an FAQ on monoclonal antibody treatment.
• K-12 Schools Reopening Framework and Guidance Q&A (3/30/2021)
  • This updated guidance reflects CDC physical distancing updates and status updates to the Safety Review Process.